BIEL is the most undervalued company on the market
Post# of 8119
(Total Views: 122)
Posted On: 03/12/2025 1:32:21 PM
BIEL is the most undervalued company on the market and SIMPLE TO ANALYZE!
Q3 2021 was BIEL's only profitable quarter ($22,381) with $414,700 revenue (including $100k+ in covid relief funds). PROFITABILITY IS VERY CLOSE! Seems like $1.5 million annual revenue (or a $400k quarter) should do it, due to BIEL's extremely low operating costs and business model. Then the corresponding pps should hit .01 - and increase .01 for each additional $2.5 million annual revenue (P/E = 100).
BIEL is a Venture Capitalist Dream! The opportunity to get in on the "next big thing", but with a company that has been in business for over 20 years (rather than a start-up). BIEL is probably the closest that any of us will get to having a venture capital kind of opportunity.
1) BIEL products have Standard of Care pain management potential for every adult and pet on the planet.
2) BIEL has 5 FDA clearances (with more pending) and the products work extremely well (some say like a miracle).
3) Upside ROI is huge (>10,000%) with minimal downside risk!
BIEL IS THE NEXT AMAZON /APPLE (in terms of ROI)!
When BIEL hits .006, the return on investment for a .0002 buy (for those of us fortunate enough to get them recently) will be about the same as the 10-year ROI (3,000%) for Amazon and Apple (stocks I sold too soon). Microsoft 10-year ROI is ONLY 900%. BIEL can hit .006 in IN THE BLINK OF AN EYE, as $1.5 annual revenue (or a $400k quarter) should do it (due to BIEL's extremely low operating costs and business model). There are many indications that this will be accomplished soon, if it hasn't been already! We know that Taiwan, the VA, South Africa and Bulgaria are in progress, as is RecoveryRx-Veterinary in Europe (with the USA pending). Canada is expanding, New Zealand sales started March 1 and hopefully Australia will soon follow. These new revenue streams should be in addition to the $700k+ earned in each of the past two years.
EXPECT A 5,000% ROI = .01 (from .0002) if BIEL reports a profit April 1 (2024 financial report) - or if management hints Q1 (2025) was profitable - which would put it among the all-time greatest stocks.
CoPilot: Achieving a 5,000% return on investment (ROI) is rare and typically involves high-risk stocks, often in emerging industries or during market booms. Some penny stocks, for example, have been highlighted for their potential to deliver such returns, like Applied Digital (APLD), OppFi (OPFI), and Blue Hat Interactive (BHAT).
Q3 2021 was BIEL's only profitable quarter ($22,381) with $414,700 revenue (including $100k+ in covid relief funds). PROFITABILITY IS VERY CLOSE! Seems like $1.5 million annual revenue (or a $400k quarter) should do it, due to BIEL's extremely low operating costs and business model. Then the corresponding pps should hit .01 - and increase .01 for each additional $2.5 million annual revenue (P/E = 100).
BIEL is a Venture Capitalist Dream! The opportunity to get in on the "next big thing", but with a company that has been in business for over 20 years (rather than a start-up). BIEL is probably the closest that any of us will get to having a venture capital kind of opportunity.
1) BIEL products have Standard of Care pain management potential for every adult and pet on the planet.
2) BIEL has 5 FDA clearances (with more pending) and the products work extremely well (some say like a miracle).
3) Upside ROI is huge (>10,000%) with minimal downside risk!
BIEL IS THE NEXT AMAZON /APPLE (in terms of ROI)!
When BIEL hits .006, the return on investment for a .0002 buy (for those of us fortunate enough to get them recently) will be about the same as the 10-year ROI (3,000%) for Amazon and Apple (stocks I sold too soon). Microsoft 10-year ROI is ONLY 900%. BIEL can hit .006 in IN THE BLINK OF AN EYE, as $1.5 annual revenue (or a $400k quarter) should do it (due to BIEL's extremely low operating costs and business model). There are many indications that this will be accomplished soon, if it hasn't been already! We know that Taiwan, the VA, South Africa and Bulgaria are in progress, as is RecoveryRx-Veterinary in Europe (with the USA pending). Canada is expanding, New Zealand sales started March 1 and hopefully Australia will soon follow. These new revenue streams should be in addition to the $700k+ earned in each of the past two years.
EXPECT A 5,000% ROI = .01 (from .0002) if BIEL reports a profit April 1 (2024 financial report) - or if management hints Q1 (2025) was profitable - which would put it among the all-time greatest stocks.
CoPilot: Achieving a 5,000% return on investment (ROI) is rare and typically involves high-risk stocks, often in emerging industries or during market booms. Some penny stocks, for example, have been highlighted for their potential to deliver such returns, like Applied Digital (APLD), OppFi (OPFI), and Blue Hat Interactive (BHAT).
(2)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼